Skip to content

Family Disclosure in Cascade Testing

Family Disclosure in Cascade Testing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04168736
Enrollment
50
Registered
2019-11-19
Start date
2017-06-30
Completion date
2018-12-30
Last updated
2019-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic Predisposition

Keywords

genetic testing, cascade, family disclosure

Brief summary

Prospective cohort study to evaluate the feasibility and acceptability of using standardized educational and communication tools to assist in communication of genetic test results to family members. A pre and post test will be administered to consented patients before and after genetic counseling .

Detailed description

This will be a prospective cohort study to evaluate 1) the feasibility and acceptability of using standardized educational and communication tools to assist in communication of genetic test results to family members, 2) utility of the communication tool, and 3) the impact of a patient focused information sheet on the knowledge of genetic testing in women who attend the women's oncology clinic. Genetic counseling is recommended for all women with a diagnosis of ovarian cancer, most patients with pre-menopausal diagnosis of breast cancer, and in younger women with uterine or other gynecologic malignancies. Women with a diagnosis of breast or gynecologic cancer who elect to undergo genetic testing will be approached to participate in this study. If they consent, they will be provided with two information handouts (FORCE sharing worksheets) and family letter template. Participants will complete a baseline knowledge survey prior to receipt of these materials. At a second visit, they will complete the knowledge survey again. Knowledge surveys will be scored and pre and post test scores will be compared with a paired t-test. Feasibility will be assessed by tracking the number of patients approached to participate, the number who sign consents, and the number who complete the study.

Interventions

OTHERFeasibility and Acceptability of Genetic Counseling Materials

To determine the feasibility and acceptability of a communication aid in sharing genetic test results with family members. To determine the utility of a communication aid in sharing information. To determine the impact of patient focused information sheets on patient knowledge of genetic testing.

Sponsors

University of Virginia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 * Diagnosis of breast or gynecologic cancer * Undergoing any genetic testing at UVA for standard clinical purposes in the Women's Oncology Clinic

Exclusion criteria

* Not receiving treatment at UVA * Not English literate * Unable to provide consent * Known pregnancy (self-reported)

Design outcomes

Primary

MeasureTime frameDescription
percentage of family members told in comparison to number of family members1 yearEvaluate the feasibility and acceptability of using standardized educational and communication tools to assist in communication of genetic test results to family members

Secondary

MeasureTime frameDescription
To compare pre- and post test scores to accesses the gaps in traditional genetic counseling education sessions1 yearEvaluate the impact of a patient focused information sheet on the knowledge of genetic testing in women who attend the women's oncology clinic
percentage of participants that report using the intervention1 yearEvaluate the utility of the communication tool

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026